Skip to content

News & updates

Press Releases

MSD Study Validates Performance of MiRXES qPCR Platform for microRNA Biomarker Development

11 March, 2021

A*STAR, TTSH and MiRXES launch multiplex COVID-19 kit that tests for SARS-CoV-2 and Influenza A and B

18 January, 2021

MiRXES and NUHS launch GASTROClear blood test for early detection of gastric cancer

23 October, 2020

Data from pulmonary hypertension collaboration with Janssen-J&J presented at ERS Congress 2020

8 September, 2020

Webinar: Launch of SS 656 Design, Development and Validation of miRNA-based Diagnostics (Video)

4 September, 2020

MiRXES launches Japan subsidiary

1 June, 2020

MiRXES partners Esco Aster for mobile COVID-19 diagnostic labs

18 May, 2020

MiRXES to mass produce and distribute A*STAR Singapore’s tested and proven SARS-CoV-2 RT-PCR test

23 April, 2020

MiRXES collaborates with NUS and DxD Hub to move Singapore to the forefront of global microRNA research and application

29 January, 2020
« Prev12Next »

Media Coverage

Success Stories: MiRXES Japan
18 March, 2021 /
MiRXES test kit that can detect COVID-19 and seasonal flu gets HSA’s approval
18 January, 2021 /
COVID-19 and the coming of age of Singapore science
14 December, 2020 /
MiRXES Chief Scientific Advisor in SWITCH 2020 Video: 25 People, One Story (Video)
10 December, 2020 /
MiRXES CEO on SWITCH 2020 panel: Internationalisation of deep tech (Video)
9 December, 2020 /
MiRXES sets out to sell gastric cancer test across Asia
4 November, 2020 / ,
Channel News Asia report on GASTROClear (Video)
23 October, 2020 /
GASTROClear being evaluated for use in primary healthcare
23 October, 2020 /
IPOS Innovation for Humanity Award for MiRXES (Video)
25 August, 2020 /
Singapore ramps up test kit production to meet local and global demand
19 August, 2020 /
MiRXES and other homegrown firms in virus fight
11 August, 2020 /
MiRXES leading the way in microRNA technology
21 May, 2020 /
Home-grown firms linked to pandemic work will continue to attract demand, investments
10 May, 2020 /
MiRXES is 102nd on Financial Times ranking of Asia-Pacific High Growth Companies
21 April, 2020 /
COVID-19 putting MiRXES and Singapore on global deeptech radar
14 April, 2020 /
MiRXES heeding the call for COVID-19 testing
30 March, 2020 /
MiRXES — A game changer in microRNA applications
3 March, 2020 /
Singapore clears Fortitude Kit SARS-CoV-2 test for clinical use
3 March, 2020 /
MiRXES to mass-produce Singapore-developed Fortitude Kit SARS-CoV-2 test kits
18 February, 2020 / ,
MiRXES named Singapore’s fastest growing company in the health sector from 2015-2018
15 January, 2020 /
Timely guidance for MiRXES from Pro-Enterprise Panel
7 November, 2019 /
GASTROClear blood test for stomach cancer first step to ending all cancer deaths
18 September, 2019 /
MiRXES has a real shot at stamping out cancer deaths
8 July, 2019 /
Seniors tested for stomach cancer with GASTROClear at free screening in Teck Ghee
18 May, 2019 /
MiRXES co-founder Zhou Lihan’s entrepreneurial journey
14 May, 2018 /
MiRXES collaborates with Johnson & Johnson to develop miRNA test for lung cancer
16 January, 2018 /
MiRXES aims to make cancer tests more accessible
21 November, 2016 /
Venturecraft invests in MiRXES
6 September, 2016 /
MiRXES creates alternative test for cancer
23 August, 2016 /
« Prev12Next »